Publications

Authors: Michael Vallis, Lori Berard, Emmanuel Cosson, Finn Boerlum Kristensen, Fleur Levrat-Guillen, Nicolas Naiditch, Remi Rabasa-Lhoret, William Polonsky Abstract No Abstract Available Source: https://pubmed.ncbi.nlm.nih.gov/39984124/

Authors: Viral N Shah, Terry Dex, Luigi Meneghini, Amélie Rodrigues, William H Polonsky Abstract Aims: In Soli-CGM, treatment with iGlarLixi (insulin glargine 100 U/mL and lixisenatide 33 μg/mL) in insulin-naive adults with suboptimally controlled type 2 diabetes (T2D; haemoglobin A1c 9%-13% on ≥2 oral antihyperglycaemic agents (OADs) ± glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy) increased time in range (TIR; primary

Authors: Marisa Kostiuk, E Seth Kramer, Andrea Nederveld, Danielle M Hessler, Lawrence Fisher, Jessica A Parascando, Tamara K Oser Abstract Purpose of review: Addressing diabetes distress (DD), the emotional demands of living with diabetes, is a crucial component of diabetes care. Most individuals with type 2 diabetes and approximately half of adults with type 1 diabetes receive their care in the

Authors: Daniel Moore, Natasha Leibel, William Polonsky, Henry Rodriguez. Plain language summary What is this summary about? Type 1 diabetes is an autoimmune disease. This means that the body’s immune system mistakenly attacks the beta cells, the type of cell that makes the hormone insulin, in the pancreas. Insulin allows a person to use energy from food and controls blood

Authors: William Polonsky, Emily Soriano, Lisa Strycker, Lawrence Fisher. Abstract Background: Recent advances in diabetes care and technology, such as real-time continuous glucose monitoring, can help people live more freely, with more flexibility and fewer constraints, thereby enhancing quality of life (QOL). To date, there has been no validated means for measuring this key psychological dimension. We developed the Diabetes

Authors: Katharine Barnard-Kelly, David Marrero, Maartie de Wit, Frans Pouwer, Kamlesh Khunti, Norbert Hermans, Jessica Pierce, Lori Laffel, Richard Holt, Tadei Battelino, Diana Naranjo, Jacqueline Fosbury, Lawrence Fisher, William Polonsky, Jill Weissberg-Benchell, Korey Hood, Oliver Schnell, Laurel Messer, Thomas Danne, Revital Nimri, Soren Akovlund, Julia Mader, Jennifer Sherr, Desmond Schatz, Simon O’Neill, Emma Doble, Marissa Town, Karin Lange, Carine de

Authors: Lawrence Fisher, Susan Guzman, William Polonsky, Danielle Hessler Abstract Aims: Diabetes distress (DD) refers to the emotional and behavioural challenges associated with managing this demanding chronic disease over time. DD is alarmingly common and it has a significant impact on self-management behaviours and clinical outcomes. Thus, there is growing recognition that DD is a pressing problem that deserves careful attention

Authors: William Polonsky, Malik Benamar, Lisbeth Carstensen, Melanie Davies, Anders Meller Donatsky, Edward Franek, Monika Kellerer, Athena Philis-Tsimikas, Ronald Goldenberg Abstract Aims: The ONWARDS phase 3a clinical trials evaluated once-weekly insulin icodec (icodec) versus once-daily basal insulin in type 2 diabetes. This analysis investigated the treatment-related experiences of participants from ONWARDS 5 and 2, and physicians from ONWARDS 1. Methods: Patient-reported outcomes

Authors: Sarah A MacLeish, Korey K Hood, William H Polonsky, Jamie R Wood, Bruce W Bode, Gregory P Forlenza, Lori M Laffel, Bruce A Buckingham, Amy B Criego, Melissa J Schoelwer, Daniel J DeSalvo, Jennifer L Sherr, David W Hansen, Lindsey R Conroy, Lauren M Huyett, Todd E Vienneau, Trang T Ly; Omnipod 5 in Preschoolers Study Group Abstract Aim: Automated

Authors: Eden Miller, Steve Edelman, Carlos Campos, John E Anderson, Christopher G Parkin, William H Polonsky Abstract Objectives: To discuss the social, psychological, and access barriers that inhibit weight loss, and to propose steps and initiatives for addressing the growing obesity epidemic. Study design: Narrative review of the obesity epidemic in the US and associated racial/ethnic and socioeconomic disparities. Methods: